Mestastop is tackling the biggest challenge in cancer—metastasis, which causes 90% of cancer deaths but remains largely unaddressed by current therapies. We bridge the gap with our proprietary platforms—METAssay, METSCAN, and METVivo—designed to accelerate metastasis-targeting drug discovery. Our solutions offer advanced in vitro and in vivo models that closely mimic metastatic biology without compromising cost or timelines.
